NCT02669017 2021-05-19Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)ADC Therapeutics S.A.Phase 1 Completed183 enrolled 38 charts